The first stop for professional medicines advice

Patient Group Directions

139 results

RelevanceNewest firstOldest firstTitle
Applied filters

Implementing the National Patient Group Direction (PGD) Templates

4 October 2021SPS national PGD templates can be implemented by organisations to improve consistency and reduce duplication of effort.

Etonogestrel (e.g. Nexplanon®) implant for contraception

4 October 2021A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).

Lidocaine injection for subdermal etonogestrel in contraception

4 October 2021A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off label')

Retaining legal mechanism documentation

10 June 2021Advice on the retention of all records relating to legal mechanisms (e.g. PGDs, Written Instruction, National Protocol)

Patient Group Directions in Complex Commissioning Scenarios

10 June 2021This guide supports planning, decision making and advises on governance processes when PGDs are used within commissioned services.

Repeat supply or administration of medicines under PGD

26 April 2021The below article details the position regarding use of a PGD to make repeat supplies/repeated administrations of a medicine.

Extension of expiry date of a Patient Group Direction

26 April 2021This Q&A advises on the extension to the expiry date of a PGD where a full review and re-authorisation has not taken place.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Patient Group Directions